Pfizer will allow its Covid treatment pill to be made and sold inexpensively in 95 poorer nations.

The deal could help significantly expand access to the pill, but it excludes a number of countries hit hard by the pandemic.

Breaking News: Pfizer will allow its Covid treatment pill to be made and sold inexpensively in 95 poorer nations. The deal could help significantly expand access to the pill, but it excludes a number of countries hit hard by the pandemic.https://t.co/9DAZTVUUcl

— The New York Times (@nytimes) November 16, 2021

Pfizer says its antiviral COVID-19 pill is 89% effective in preventing hospitalizations

Pfizer says its antiviral COVID-19 pill is 89% effective at prevent hospitalizations and 100% effective against deaths from the virus if taken within three days of a person experiencing symptoms. Dr. John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the potentially life-saving drug.

Pfizer to allow broader global access to its experimental COVID-19 antiviral pill https://t.co/mrrMJ3q0IU

— ABC7 News (@abc7newsbayarea) November 16, 2021